¥2,469.00
3.35% day before yesterday
Tokyo, Nov 21, 07:15 am CET
Why the stock moved Why the stock moved Beta
ISIN
JP3546800008
Symbol
4543
Index

Terumo Stock price

¥2,460.00
-94.50 3.70% 1M
-235.50 8.74% 6M
-602.00 19.66% YTD
-578.00 19.03% 1Y
+485.50 24.59% 3Y
+428.00 21.06% 5Y
+1,446.25 142.66% 10Y
+2,030.00 472.09% 20Y
Tokyo, Closing price Fri, Nov 21 2025
+71.00 2.97%
ISIN
JP3546800008
Symbol
4543
Index

New AI Insights on Terumo Insights AI Insights on Terumo

How does the company make money?
Who are the company’s main competitors?
What are the key opportunities and risks?

Key metrics

Basic
Market capitalization
¥3.6t
Enterprise Value
¥3.6t
Net debt
positive
Cash
¥217.3b
Shares outstanding
1.5b
Valuation (TTM | estimate)
P/E
27.8 | 23.9
P/S
3.4 | 3.4
EV/Sales
3.4 | 3.3
EV/FCF
28.4
P/B
2.5
Dividends
DPS
¥30.00
Yield 1Y | 5Y
1.2% | 1.0%
Growth 1Y | 5Y
15.4% | 15.7%
Payout 1Y | 3Y
32.9% | 32.4%
Increased
7 Years
Financials (TTM | estimate)
Revenue
¥1.1t | ¥1.1t
EBITDA
¥257.4b | ¥285.7b
EBIT
¥170.9b | ¥191.9b
Net Income
¥130.7b | ¥151.7b
Free Cash Flow
¥126.1b
Growth (TTM | estimate)
Revenue
7.7% | 4.3%
EBITDA
5.9% | 36.7%
EBIT
6.0% | 5.9%
Net Income
9.4% | 29.7%
Free Cash Flow
10.5%
Margin (TTM | estimate)
Gross
54.2%
EBITDA
24.2% | 26.4%
EBIT
16.1%
Net
12.3% | 14.0%
Free Cash Flow
11.9%
Financial Health
Equity Ratio
74.9%
Return on Equity
8.6%
ROCE
10.7%
ROIC
8.9%
Debt/Equity
0.1
More
EPS
¥88.6
FCF per Share
¥85.5
Short interest
-
Employees
28k
Rev per Employee
¥36.6m
Show more

Is Terumo a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,049 stocks worldwide.

Terumo Stock Analysis

Unlock Scores for Free

Analyst Opinions

21 Analysts have issued a Terumo forecast:

16x Buy
76%
5x Hold
24%

Analyst Opinions

21 Analysts have issued a Terumo forecast:

Buy
76%
Hold
24%

Financial data from Terumo

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '25
+/-
%
1,062,416 1,062,416
8% 8%
100%
- Direct Costs 486,304 486,304
6% 6%
46%
576,112 576,112
9% 9%
54%
- Selling and Administrative Expenses 386,772 386,772
6% 6%
36%
- Research and Development Expense - -
-
-
257,383 257,383
6% 6%
24%
- Depreciation and Amortization 86,448 86,448
6% 6%
8%
EBIT (Operating Income) EBIT 170,935 170,935
6% 6%
16%
Net Profit 130,671 130,671
9% 9%
12%

In millions JPY.

Don't miss a Thing! We will send you all news about Terumo directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Terumo Corp. engages in the manufacturing and sale of medical products and equipment. It operates through the following segments: Cardiac and Vascular Company, General Hospital Company, and Blood Management Company. The Cardiac and Vascular Company segment offers services and treatments including cardiac and vascular surgery and interventional therapies performed inside blood vessels. The General Hospital Company segment provides infusion and closed anticancer drug infusion systems, measuring devices system with communication functions, diabetes management, adhesion barrier, and peritoneal dialysis. The Blood Management Company segment offers a combination of apheresis collections, manual and automated whole blood processing, and pathogen reduction. The company was founded by Shibasaburo Kitasato on September 17, 1921 and is headquartered in Tokyo, Japan

Head office Japan
CEO Hikaru Samejima
Employees 28,294
Founded 1921
Website www.terumo.co.jp

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today